Abstract
DISTRIBUTION OF GENES ENCODING ERYTHROMYCIN RIBOSOMAL METHYLASES AND MACROLIDE EFFLUX PUMP IN METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS ISOLATES FROM TERTIARY CARE HOSPITALS IN TAMIL NADU.

Stalin M., Saravanan M. and Padma Krishnan*

ABSTRACT

The increasing frequency of the infections with MRSA and the changing drug susceptibility pattern have led to renewed interest in the use of Macrolide Lincosamide Streptogramin-B (MLSB) antibiotic to treat these infections. Resistance to macrolide and lincosamide is prevalent among staphylococci in recent days. Hence this study was aimed to undertake the detection of resistance determinants of macrolide and methicillin resistant S. aureus isolates. A total of 237 Staphylococcus aureus isolates collected during 2013-2014, from various tertiary care hospitals were included in this study. MLSBi (inducible clindamycin resistance) was screened by using D- test. Confirmation of MRSA was done by molecular detection of mecA and femA gene. Detection of erythromycin resistance genes (ermA, ermC) and macrolide efflux (msrA) resistance genes was done by multiplex PCR. Of the 237 Staphylococcus aureus isolates, 150 (63%) expressed resistance to erythromycin, 46 isolates were MSSA and 104 were MRSA. Our study showed MLSBi in 35% of MRSA and 15% of MSSA. Among MRSA, the most prevalent resistant determinant was ermA (22%), ermC in 9%, msrA in 16% of isolates, whereas 20% of isolates harboured multiple resistance mechanisms. Among MSSA, ermA gene was found in 22% of isolates, ermC in 9%, msrA in 4% of isolates, while 9% of isolates harboured multiple resistance mechanisms. In conclusion, 20% of isolates were detected in combination of erm genes with other resistance gene msrA. Though ermA gene was most prevalent, but isolates exhibits multiple resistance mechanism was found to be high in our study, which was less frequently reported.

Keywords: (D-Test, MLSB, msrA gene and erm gene).


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MAY ISSUE PUBLISHED

    MAY 2022 Issue has been successfully launched on 1 May 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT